Haemonetics director Martin D. Madaus files initial beneficial ownership statement

PUBT · 1d ago
Haemonetics director Martin D. Madaus files initial beneficial ownership statement
  • Haemonetics filed an initial Section 16 Form 3 for director Martin D. Madaus, triggered by an event dated July 24, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Haemonetics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000313143-26-000097), on July 28, 2026, and is solely responsible for the information contained therein.